BioHarvest Sciences Inc. announced a non-brokered private placement of convertible notes for the gross proceeds of CAD 12,000,000 on October 19, 2023. The notes will have a term of 24 months, and pay interest of 12% per annum. The convertible notes and accrued interest will be convertible at the option of the holder into common shares of the Issuer at a conversion price that is equal to the closing market price of the company?s common shares on the date of conversion less a discount of 20% but in any event, not less than CAD 0.24 per share or more than CAD 0.75 per share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 CAD | +2.13% | -5.88% | +11.63% |
1st Jan change | Capi. | |
---|---|---|
+11.63% | 101M | |
+16.80% | 8.43B | |
+7.94% | 7.8B | |
+15.02% | 6.82B | |
-4.77% | 3.77B | |
-6.75% | 3.74B | |
+4.41% | 1.44B | |
-30.34% | 1.06B | |
+20.28% | 1.04B | |
-12.85% | 890M |
- Stock Market
- Equities
- BHSC Stock
- News BioHarvest Sciences Inc.
- BioHarvest Sciences Inc. announced that it expects to receive CAD 12 million in funding